Related Experiment Video
Updated: Apr 23, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Comparison of Hospitalization Costs Associated With Human Metapneumovirus and Respiratory Syncytial Virus Infection
Bradley K Ackerson1, Emily Rayens1, Lina S Sy1
1Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Abstract:
Hospitalization costs on human metapneumovirus (hMPV) are needed to inform healthcare priorities, including vaccine and treatment development. Among 5775 adult hospitalizations with hMPV or respiratory syncytial virus (RSV), hMPV was associated with shorter length of stay but greater frequency of pneumonia, resulting in adjusted mean costs comparable to RSV hospitalization.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Influenza
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Viral Meningitis

